| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |